BioNTech (BNTX) News Today → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free BNTX Stock Alerts $93.94 -3.01 (-3.10%) (As of 03:45 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 1:57 PM | markets.businessinsider.comReiterating Buy on BioNTech Amid Strategic Growth and Upcoming CatalystsMay 27 at 10:33 PM | msn.comModerna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?May 27 at 8:47 AM | marketbeat.comNeuberger Berman Group LLC Makes New $1.56 Million Investment in BioNTech SE (NASDAQ:BNTX)Neuberger Berman Group LLC purchased a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 14,800 shares of the company's stock, valued at appMay 26 at 8:00 PM | prnewswire.comMediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnershipMay 26 at 5:51 AM | marketbeat.comRobeco Institutional Asset Management B.V. Trims Holdings in BioNTech SE (NASDAQ:BNTX)Robeco Institutional Asset Management B.V. reduced its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 18.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,790 shares of the companyMay 26 at 3:42 AM | americanbankingnews.comBioNTech's (BNTX) Buy Rating Reaffirmed at HC WainwrightMay 25 at 7:48 AM | americanbankingnews.comBioNTech (NASDAQ:BNTX) Sees Unusually-High Trading VolumeMay 25 at 1:44 AM | americanbankingnews.comBioNTech SE Forecasted to Earn Q2 2024 Earnings of ($1.76) Per Share (NASDAQ:BNTX)May 25 at 12:56 AM | marketbeat.comPrimecap Management Co. CA Acquires 131,490 Shares of BioNTech SE (NASDAQ:BNTX)Primecap Management Co. CA lifted its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 2.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 4,763,453 shares of the company's stock after purchasing an additional 131,490 shares during the pMay 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioNTech SE on Strong Pipeline and Strategic ExpansionMay 24, 2024 | markets.businessinsider.comCritical Insights From BioNTech Analyst Ratings: What You Need To KnowMay 24, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Down 2.4% BioNTech (NASDAQ:BNTX) Trading Down 2.4%May 24, 2024 | marketbeat.comBioNTech SE to Post Q2 2024 Earnings of ($1.76) Per Share, Leerink Partnrs Forecasts (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Free Report) - Leerink Partnrs issued their Q2 2024 earnings per share (EPS) estimates for BioNTech in a research note issued to investors on Wednesday, May 22nd. Leerink Partnrs analyst D. Graybosch forecasts that the company will post earnings of ($1.76) per share forMay 24, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $113.00 target price on shares of BioNTech in a report on Friday.May 24, 2024 | fool.comWhy Vaccine Stocks Rallied This WeekMay 24, 2024 | markets.businessinsider.comBuy Rating on BioNTech SE Amidst Undervaluation and Strong Pipeline ProspectsMay 23, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Sees Strong Trading VolumeBioNTech (NASDAQ:BNTX) Sees Unusually-High Trading VolumeMay 23, 2024 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Purchased by Clearbridge Investments LLCClearbridge Investments LLC increased its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 506,692 shares of the company's stock aftMay 23, 2024 | americanbankingnews.comTraders Buy Large Volume of Call Options on BioNTech (NASDAQ:BNTX)May 22, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Up 6.1%BioNTech (NASDAQ:BNTX) Stock Price Up 6.1%May 22, 2024 | marketbeat.comBioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 2,346 call options on the company. This represents an increase of approximately 59% compared to the typical daily volume of 1,477 call options.May 21, 2024 | globenewswire.comBioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024May 21, 2024 | globenewswire.comMedigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced TermMay 17, 2024 | marketbeat.comBeacon Pointe Advisors LLC Purchases Shares of 52,706 BioNTech SE (NASDAQ:BNTX)Beacon Pointe Advisors LLC purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 52,706 shares of the company's stock, valuedMay 17, 2024 | theglobeandmail.comModerna wins COVID shot patent case against Pfizer-BioNTech in EuropeMay 17, 2024 | reuters.comModerna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reportsMay 17, 2024 | globenewswire.comBioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024May 15, 2024 | marketbeat.comNatixis Advisors L.P. Makes New $1.66 Million Investment in BioNTech SE (NASDAQ:BNTX)Natixis Advisors L.P. bought a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 15,766 shares of the company's stock, valued at approximately $1,66May 14, 2024 | marketbeat.comShort Interest in BioNTech SE (NASDAQ:BNTX) Grows By 16.8%BioNTech SE (NASDAQ:BNTX - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,690,000 shares, a growth of 16.8% from the April 15th total of 3,160,000 shares. Currently, 1.6% of the company's shares are sold short. Based on an average trading volume of 594,100 shares, the days-to-cover ratio is currently 6.2 days.May 14, 2024 | msn.comEvercore ISI Group Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with In-Line RecommendationMay 12, 2024 | marketbeat.comTruist Financial Corp Buys Shares of 13,694 BioNTech SE (NASDAQ:BNTX)Truist Financial Corp purchased a new position in BioNTech SE (NASDAQ:BNTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 13,694 shares of the company's stock, valued at approximately $1,445,000. A number of other institutional investMay 11, 2024 | finance.yahoo.comWe Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This YearMay 10, 2024 | marketbeat.comBioNTech SE (NASDAQ:BNTX) to Post Q1 2025 Earnings of ($2.31) Per Share, HC Wainwright ForecastsBioNTech SE (NASDAQ:BNTX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Wednesday, May 8th. HC Wainwright analyst R. Burns expects that the company will post earnings of ($2.31) per shareMay 8, 2024 | markets.businessinsider.comDeutsche Numis Reaffirms Their Hold Rating on BioNTech SE (BNTX)May 8, 2024 | finance.yahoo.comBioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 8, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Price Target Raised to $113.00HC Wainwright boosted their target price on BioNTech from $107.00 to $113.00 and gave the stock a "buy" rating in a report on Wednesday.May 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioNTech Amid Strong Financials and Promising Oncology PipelineMay 7, 2024 | markets.businessinsider.comStrong Financials and Promising Oncology Pipeline Support Buy Rating for BioNTech SEMay 7, 2024 | msn.comBioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market SessionMay 7, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) PT Lowered to $122.00BMO Capital Markets decreased their target price on BioNTech from $123.00 to $122.00 and set an "outperform" rating for the company in a research report on Tuesday.May 7, 2024 | markets.businessinsider.comBuy Rating for BioNTech SE on Strong H2 Revenue Outlook and Promising Oncology PipelineMay 7, 2024 | markets.businessinsider.comBioNTech: Hold Rating Maintained Amidst Lower Q1 Earnings and Steady Revenue OutlookMay 6, 2024 | msn.comBioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents ToplineMay 6, 2024 | finance.yahoo.comWhat's Going With BioNTech Stock On Monday?May 6, 2024 | fool.comBioNTech Se (BNTX) Q1 2024 Earnings Call TranscriptMay 6, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Down to $92.72BioNTech (NASDAQ:BNTX) Shares Gap Down to $92.72May 6, 2024 | investorplace.comBNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | seekingalpha.comBioNTech SE 2024 Q1 - Results - Earnings Call PresentationMay 6, 2024 | investopedia.comBioNTech's Outlook Gives Vaccine Maker a Shot in the ArmMay 6, 2024 | barrons.comBioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long BNTX Media Mentions By Week BNTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.730.92▲Average Medical News Sentiment BNTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼279▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Gilead Sciences News Today Moderna News Today Biogen News Today argenx News Today Neurocrine Biosciences News Today Bio-Techne News Today Qiagen News Today Repligen News Today Vaxcyte News Today Revolution Medicines News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesWARNING about the death of the U.S. dollar…Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
